OBIO
Income statement / Annual
Last year (2023), Orchestra BioMed Holdings, Inc.'s total revenue was $2.76 M,
a decrease of 21.88% from the previous year.
In 2023, Orchestra BioMed Holdings, Inc.'s net income was -$49.12 M.
See Orchestra BioMed Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$2.76 M
|
$3.53 M
|
-$782,000.00
|
$5.70 M
|
| Cost of Revenue |
$186,000.00 |
$322,000.00 |
$199,000.00 |
$145,000.00 |
| Gross Profit |
$2.57 M |
$3.21 M |
-$981,000.00 |
$5.56 M |
| Gross Profit Ratio |
0.93 |
0.91 |
1.25 |
0.97 |
| Research and Development
Expenses |
$33.82 M
|
$21.95 M
|
$12.89 M
|
$13.48 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$20.26 M
|
$13.92 M
|
$7.93 M
|
$10.83 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$54.08 M |
$35.87 M |
$20.82 M |
$24.31 M |
| Cost And Expenses |
$54.27 M |
$36.19 M |
$21.02 M |
$24.46 M |
| Interest Income |
$3.85 M |
$50,000.00 |
$927,000.00 |
$331,000.00 |
| Interest Expense |
$0.00 |
$0.00 |
$927,000.00 |
$0.00 |
| Depreciation &
Amortization |
$287,000.00
|
$222,000.00
|
$181,000.00
|
$137,000.00
|
| EBITDA |
-$51.22 M
|
-$32.44 M
|
-$21.62 M
|
-$18.62 M
|
| EBITDA Ratio |
-18.56 |
-9.18 |
27.64 |
-2.75 |
| Operating Income Ratio
|
-18.66
|
-9.24
|
27.88
|
-3.29
|
| Total Other
Income/Expenses Net |
$2.39 M
|
-$951,001.00
|
-$1.22 M
|
-$2.60 M
|
| Income Before Tax |
-$49.12 M |
-$33.61 M |
-$23.01 M |
-$21.36 M |
| Income Before Tax Ratio
|
-17.8
|
-9.51
|
29.43
|
-3.74
|
| Income Tax Expense |
$0.00 |
-$221,999.00 |
$927,000.00 |
$2.60 M |
| Net Income |
-$49.12 M |
-$33.61 M |
-$23.01 M |
-$21.36 M |
| Net Income Ratio |
-17.8 |
-9.51 |
29.43 |
-3.74 |
| EPS |
-1.48 |
-2.24 |
-1.13 |
-1.04 |
| EPS Diluted |
-1.48 |
-2.24 |
-1.13 |
-1.04 |
| Weighted Average Shares
Out |
$33.23 M
|
$14.99 M
|
$20.45 M
|
$20.45 M
|
| Weighted Average Shares
Out Diluted |
$33.23 M
|
$14.99 M
|
$20.45 M
|
$20.45 M
|
| Link |
|
|
|
|
